1. Home
  2. LEGN vs CHRD Comparison

LEGN vs CHRD Comparison

Compare LEGN & CHRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • CHRD
  • Stock Information
  • Founded
  • LEGN 2014
  • CHRD 2007
  • Country
  • LEGN United States
  • CHRD United States
  • Employees
  • LEGN N/A
  • CHRD N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • CHRD Oil & Gas Production
  • Sector
  • LEGN Health Care
  • CHRD Energy
  • Exchange
  • LEGN Nasdaq
  • CHRD Nasdaq
  • Market Cap
  • LEGN 7.0B
  • CHRD 6.7B
  • IPO Year
  • LEGN 2020
  • CHRD 2010
  • Fundamental
  • Price
  • LEGN $39.70
  • CHRD $111.67
  • Analyst Decision
  • LEGN Strong Buy
  • CHRD Buy
  • Analyst Count
  • LEGN 12
  • CHRD 13
  • Target Price
  • LEGN $79.50
  • CHRD $173.08
  • AVG Volume (30 Days)
  • LEGN 976.3K
  • CHRD 843.7K
  • Earning Date
  • LEGN 03-10-2025
  • CHRD 02-25-2025
  • Dividend Yield
  • LEGN N/A
  • CHRD 9.09%
  • EPS Growth
  • LEGN N/A
  • CHRD N/A
  • EPS
  • LEGN N/A
  • CHRD 18.95
  • Revenue
  • LEGN $520,183,000.00
  • CHRD $4,448,171,000.00
  • Revenue This Year
  • LEGN $121.13
  • CHRD $41.83
  • Revenue Next Year
  • LEGN $65.25
  • CHRD N/A
  • P/E Ratio
  • LEGN N/A
  • CHRD $5.89
  • Revenue Growth
  • LEGN 122.96
  • CHRD 20.68
  • 52 Week Low
  • LEGN $30.17
  • CHRD $107.24
  • 52 Week High
  • LEGN $70.13
  • CHRD $190.23
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 64.82
  • CHRD 43.54
  • Support Level
  • LEGN $34.36
  • CHRD $109.12
  • Resistance Level
  • LEGN $36.39
  • CHRD $115.78
  • Average True Range (ATR)
  • LEGN 1.67
  • CHRD 3.26
  • MACD
  • LEGN 0.34
  • CHRD 0.41
  • Stochastic Oscillator
  • LEGN 94.68
  • CHRD 49.22

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About CHRD Chord Energy Corporation

Chord Energy Corp is an independent exploration and production company. The company acquires, exploits, develops, and explores crude oil, natural gas, and natural gas liquids in the Williston Basin.

Share on Social Networks: